Jyotirmoy Roy
jyoroybme.bsky.social
Jyotirmoy Roy
@jyoroybme.bsky.social
Umich BME Ph.D. @SheLab | Working on diagnosis and prevention of Autoimmune Type 1 Diabetes using biomaterials and multi-omics
Excited to contribute as a co-first to this new article from the Shea Lab. Using a minimally invasive synthetic metastatic niche, we show how immune cells shift from tumor-fighting to tumor-supporting over time, revealing metastatic dormancy vs growth in breast cancer.
doi.org/10.1002/bit....
Dynamic Immune Cell Composition, Phenotypes, and Signaling in an Engineered Metastatic Niche
In breast cancer patients, metastasis is the stage of disease where prognosis significantly worsens. However, the timing at which metastasis initiates and the location of metastatic lesions in an org...
analyticalsciencejournals.onlinelibrary.wiley.com
January 11, 2026 at 3:27 AM
Reposted by Jyotirmoy Roy
🔥Smoking hot new paper and tweetorial from @djcalebc.bsky.social (collab with Chinnaiyan Lab)! 🔥

We are over the moon about this new work and its therapeutic implications for pancreatic cancer. Please have a read and share your thoughts/feedback! 🙏🏼
Beyond grateful to share that my main PhD thesis project, Targeting PIKfyve-driven lipid metabolism in pancreatic cancer (@lyssiotislab.bsky.social + Arul Chinnaiyan lab), has just been published in @nature.com!
April 24, 2025 at 8:20 PM
Reposted by Jyotirmoy Roy
#T1D -related TCR motif enrichment based on genetic risk, offering a potential metric for autoreactivity and basis for TCR-based diagnostics and therapeutics. www.medrxiv.org/content/10.1...
March 1, 2025 at 6:21 PM